Paragonix Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
100
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$477M
Paragonix General Information
Description
Developer of organ transportation devices designed for the security and preservation of donor organs. The company's devices maintain a consistent thermal environment, monitor real-time location, and manage case logistics on a centralized platform, enabling organ transplant healthcare providers to improve organ preservation and enhance post-transplant outcomes
Contact Information
Website
www.paragonixtechnologies.com(Operating Subsidiary)
Corporate Office
- 950 Winter Street
- North Waltham, MA 02451
- United States
Corporate Office
- 950 Winter Street
- North Waltham, MA 02451
- United States
Paragonix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 11-Sep-2024 | $477M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series B) | 07-Mar-2023 | Completed | Generating Revenue | |||
| 4. Debt - General | 05-May-2022 | Completed | Generating Revenue | |||
| 3. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 01-Feb-2019 | $8.1M | $8.1M | Completed | Generating Revenue | |
| 1. Grant | 11-Apr-2013 | $148K | Completed | Startup |
Paragonix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A | 4,590,397 | $0.000100 | 12% | $3.91 | $3.91 | 1x | $3.91 | 23.2% |
Paragonix Comparisons
Industry
Financing
Details
Paragonix Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Accuray | Formerly VC-backed | Madison, WI | ||||
| Organ Assist | Formerly VC-backed | Groningen, Netherlands | ||||
| TransMedics | Formerly VC-backed | Andover, MA | ||||
| OrganOx | Private Equity-Backed | Oxford, United Kingdom | ||||
| Organ Recovery Systems | Formerly VC-backed | Itasca, IL |
Paragonix Patents
Paragonix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1031028-S1 | Tissue suspension adaptor | Active | 08-Sep-2022 | ||
| US-20230284614-A1 | Organ transport tracking | Pending | 11-Mar-2022 | ||
| EP-4096399-A1 | Apparatus for tissue transport and preservation | Pending | 31-Jan-2020 | ||
| US-11632951-B2 | Apparatus for tissue transport and preservation | Active | 31-Jan-2020 | ||
| US-20210235691-A1 | Apparatus for tissue transport and preservation | Active | 31-Jan-2020 | A01N1/0247 |
Paragonix Executive Team (11)
| Name | Title | Board Seat |
|---|---|---|
| Lisa Anderson Ph.D | Co-Founder, Chief Executive Officer, President and Board Member | |
| Christopher Tomosivitch | Chief Financial Officer | |
| Michael Tajima | Chief Strategy Officer | |
| Jen Weddell | Chief Commercial Officer | |
| Lucas Churchill | Chief Innovation Officer |
Paragonix Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ashley Friedman | Signet Healthcare Partners | Board Member | |
| DeWitt Davenport | Self | Board Observer | |
| Emad Piracha | Signet Healthcare Partners | Board Observer | |
| Jeff Prestel | Self | Board Member | |
| John Cammett | Self | Chairman |
Paragonix Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Paragonix Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Signet Healthcare Partners | Growth/Expansion | Minority | ||
| U.S. Department of Health and Human Services | Government |
Paragonix Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Transplant Advocates | 31-Jul-2023 | Consulting Services (B2B) |
Paragonix FAQs
-
When was Paragonix founded?
Paragonix was founded in 2010.
-
Who is the founder of Paragonix?
Lisa Anderson Ph.D is the founder of Paragonix.
-
Who is the CEO of Paragonix?
Lisa Anderson Ph.D is the CEO of Paragonix.
-
Where is Paragonix headquartered?
Paragonix is headquartered in North Waltham, MA.
-
What is the size of Paragonix?
Paragonix has 100 total employees.
-
What industry is Paragonix in?
Paragonix’s primary industry is Other Devices and Supplies.
-
Is Paragonix a private or public company?
Paragonix is a Private company.
-
What is the current valuation of Paragonix?
The current valuation of Paragonix is .
-
What is Paragonix’s current revenue?
The current revenue for Paragonix is .
-
How much funding has Paragonix raised over time?
Paragonix has raised $39.3M.
-
Who are Paragonix’s investors?
Signet Healthcare Partners and U.S. Department of Health and Human Services have invested in Paragonix.
-
Who are Paragonix’s competitors?
Accuray, Organ Assist, TransMedics, OrganOx, and Organ Recovery Systems are some of the 9 competitors of Paragonix.
-
When was Paragonix acquired?
Paragonix was acquired on 11-Sep-2024.
-
Who acquired Paragonix?
Paragonix was acquired by Getinge.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
